ERJ Open Research · 2021 · 57 citations · 30 references
MedicineGeriatric MedicineImmunologyEpidemiologyInflammationSarcopeniaChronic DiseaseChronic Obstructive Pulmonary DiseaseDiagnostic Criteria For SarcopeniaMortality AnalysisRespiratory DiseaseSarcopenia In Chronic DiseaseAge-specific Morbidity PatternsCox RegressionHazard Ratio ModelingOral Corticosteroid TherapyOral Corticosteroid UseRisk Factors For SarcopeniaSex Differences In SarcopeniaSystemic Inflammation Markers
BACKGROUND: Increasing evidence suggests that sarcopenia and a higher systemic immune-inflammation index (SII) are linked with morbidity in patients with COPD. However, whether these two conditions contribute to all-cause mortality in middle-aged and older patients with COPD or asthma is unclear. Therefore, we investigated the association between sarcopenia, SII, COPD or asthma and all-cause mortality in a large-scale population-based setting. METHODS: Between 2009 and 2014, 4482 participants (aged >55 years; 57.3% female) from the population-based Rotterdam Study were included. COPD and asthma patients were diagnosed clinically and based on spirometry. Six study groups were defined according to the presence or absence of COPD or asthma and sarcopenia. Cox regression models were used to assess all-cause mortality in the study groups, adjusted for sex, age, body mass index, SII, smoking, oral corticosteroid use and comorbidities. In addition, all participants were categorised into sex-specific quartiles of SII, and mortality in these groups was compared. RESULTS: Over a median follow-up of 6.1 years (interquartile range 5.0-7.2 years), 466 (10.4%) persons died. Independent of the presence of sarcopenia, participants with COPD had a higher risk of all-cause mortality (hazard ratio (HR) 2.13, 95% CI 1.46-3.12 and HR 1.70, 95% CI 1.32-2.18 for those with and without sarcopenia, respectively). Compared to lower SII levels, higher SII levels increased mortality risk even in people without sarcopenia, COPD or asthma. CONCLUSION: Middle-aged and older people with COPD, higher SII levels or sarcopenia had an independently increased mortality risk. Our study suggests prognostic usefulness of routinely evaluating sarcopenia and SII in older people with COPD or asthma.
30
Sarcopenia: revised European consensus on definition and diagnosis
Alfonso J. Cruz‐Jentoft, Gülistan Bahat, Jürgen M. Bauer et al. · Age and Ageing · 2018 · 14K citations · Full text
Joan B. Soriano, Amanuel Alemu Abajobir, Kalkidan Hassen Abate et al. · The Lancet Respiratory Medicine · 2017 · 2.6K citations · Full text
Public Health, Chronic Disease Control, Chronic Disease Prevention +17